Feature | March 01, 2019| Dave Fornell, Editor, and A.J. Connell

Most Popular Cardiology Technology Content in February 2019

By far readers had the most interest in the recall of Stryker's LifePak15 defibrillator-monitors. The FDA said the system might lock up after after a shock is delivered, prompting the company to come up with an emergency fix on its machines.

By far readers had the most interest in the recall of Stryker's LifePak15 defibrillator-monitors. The FDA said the system might lock up after after a shock is delivered, prompting the company to come up with an emergency fix on its machines.

March 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of February 2019. This is based on website’s record 293,284 pageviews for the month:

 

1. Stryker Warns LifePak15 Defibrillators May Lock Up After Shock is Delivered

 

2. New Atrial Fibrillation Guidelines Recommend NOACs Over Warfarin

 

3. FDA Clears Biotronik Orsiro Stent That Outperforms Xience

 

4. New Directions and Trends in Coronary Metallic Stents

 

5. Higher Mortality With Impella RP May be Due to Poor Patient Selection

 

6. Leviticus Cardio and Jarvik Heart Unveil Wireless Heart Pump System

 

7. First Patient Treated With QDot Micro Ablation Catheter

 

8. ACC 2019 Late-breaking Presentations Announced

 

9. Is Echocardiography Ready for Conversion to 3-D Only?

 

10. Edwards Lifesciences Recalls Swan-Ganz Catheters Due to Incorrect Assembly

 

11. Medtronic Recalls Dual Chamber Pacemakers

 

12. 7 Trends in Interventional Lab Angiography Systems

 

13. The Data-driven Crises Involving Paclitaxel and Impella RP

 

14. FDA Approves IDE Study for Foldax Biopolymer Heart Valve Platform

 

15. VIDEO: The Cardiac Surgeon Perspective on Transcatheter Mitral Valve Repair

 

16. Le Bonheur Children's Hospital Implants First Abbott Amplatzer Piccolo Occluder

 

17. Delayed Clot Removal Still Improves Quality of Life Post-Stroke

 

18. First Tendyne Transcatheter Mitral Valve Implanted in New York

 

19. Heart Muscle Cells Created From Stem Cells Beat in Sync

 

20. 5 Key Presentations at the Society of Thoracic Surgeons Annual 2019 Meeting

 

21. New Peripheral Stent Technology

22. EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor

23. Philips and Microsoft Showcase Augmented Reality for Image-Guided Minimally Invasive Therapies

24. Scientists Discover New Heart Attack Repair Pathway

25. PreludeSync Distal Radial Compression Device Available Globally

 

Related Most Popular Content:

Most Popular Cardiology Technology Content in January 2019

The Most Popular Cardiology Topics in 2018

Most Popular Cardiology Technology Content in November 2018

Related Content

Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.
News | Cath Lab | September 21, 2021
September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Devi
Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds
An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American